NK cell-macrophage interactions in granulomas correlate with limited tuberculosis pathology.

NK cell-macrophage interactions in granulomas correlate with limited tuberculosis pathology.

Publication date: Aug 01, 2025

Development of novel vaccines and treatment approaches against tuberculosis are hampered by limited knowledge of what constitutes a protective immune response against Mycobacterium tuberculosis (Mtb). Granulomas are organized immune aggregates that form in the lung in response to mycobacterial infection and are an important site of pathogen-host interaction. The composition and cellular microenvironment within the granuloma impacts the bacterial control capacity. To identify protective responses in granulomas, imaging mass cytometry was used to study archived lung tissue from low dose Mtb-infected non-human primates presenting with various levels of disease. This approach revealed that granuloma composition is correlated with the severity of lung pathology. Granulomas of animals with limited lung pathology were enriched for NK cells showing increased interactions with tissue macrophages. This work improves our understanding of local immune interactions in the lung and how these correlate with severity of tuberculosis disease.

Open Access PDF

Concepts Keywords
Enriched Composition
Microenvironment Correlate
Mycobacterium Disease
Tuberculosis Granuloma
Vaccines Granulomas
Immune
Interactions
Limited
Lung
Mtb
Pathology
Protective
Severity
Tissue
Tuberculosis

Semantics

Type Source Name
disease IDO cell
disease MESH granulomas
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease IDO immune response
disease MESH infection
disease IDO site
disease IDO pathogen
disease IDO host
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH Infectious Diseases
disease IDO pathogen host
disease IDO organism
disease IDO bacteria
disease IDO antibiotic resistance
drug DRUGBANK BCG vaccine
disease IDO blood
drug DRUGBANK Formaldehyde
disease IDO assay
disease IDO object
drug DRUGBANK Pidolic Acid
drug DRUGBANK Dimercaprol

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *